Ticker Details
Quanterix Corporation Quanterix Corp is a life science company. The company digitizing biomarker analysis with the goal of advancing the science of precision health.
IPO Date:	December 7, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$269.05M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.72 | 3.07%
Avg Daily Range (30 D):	$0.25 | 3.67%
Avg Daily Range (90 D):	$0.20 | 3.07%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.65M
Avg Daily Volume (90 D):	.6M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	80
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	1,294
Avg Institutional Trade:	$1.32M
Avg Institutional Trade (30 D):	$1.11M
Avg Institutional Trade (90 D):	$1.08M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.26M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$1.2M
Avg Closing Volume:	47.59K

News

May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire

Apr 28, 2025 @ 10:00 PM $HAREHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc

Apr 2, 2025 @ 10:50 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc

Feb 18, 2025 @ 8:30 PM Quanterix Corporation Announcement: If You Have Su... Source: N/A

Feb 14, 2025 @ 11:30 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Conti... Source: Monteverde & Associates Pc

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.34	$-.73	$-.77
Diluted EPS	$-2.34	$-.73	$-.77
Revenue	$130.2M	$40.23M	$24.48M
Gross Profit	$67.09M	$17.21M	$11.3M
Net Income / Loss	$-95.66M	$-33.52M	$-30.01M
Operating Income / Loss	$-115.56M	$-37.33M	$-37.1M
Cost of Revenue	$63.11M	$23.03M	$13.18M
Net Cash Flow	$9.69M	$-93.9M	$56.39M
PE Ratio